Aristotle University of Thessaloniki
3rd Department of Psychiatry, Division of Neurosciences
Konstantinos N. Fountoulakis, MD, is Professor of Psychiatry at Aristotle University of Thessaloniki, AHEPA University Hospital, in Thessaloniki, Greece He is currently, zonal 8 representative (South Europe) in the Board of the World Psychiatric Association, National Representative for Mental Health in the World Health Organization and Vice-President of the Hellenic Psychiatric Association. He chairs the Mental Health Section of the Institute of Scientific Research of the Greek Medical Association. For the years 2020-1 he served as director of Cochrane Greece Dr. Fountoulakis’ areas of clinical and research interest are reflected in the topics that he teaches: general psychiatry, biological psychiatry, psychopharmacology, mood disorders, schizophrenia and personality disorders. He has coauthored more than 400 papers and more than 300 of them are published in international journals such as the LANCET, BMJ, Am J Psychiatry, British Journal of Psychiatry, Biological Psychiatry, International Journal of Neuropsychopharmacology, Journal of Affective Disorders, Schizophrenia Research, Psychiatry Research, Bipolar Disorders, and the Annals of General Psychiatry among others, approximately 15,000 citations and h=60 (Publish or Perish). During the years 2016-8 he was ranked by expertscape.com within the top 25 world experts concerning Bipolar disorder (0.068%) and among the top 50 concerning suicidality (0.097%). In 2021 he was placed among the 0.37% for year and 0.57% for the whole career of all scientists of all disciplines by the Stanford ranking. He has authored or co-authored a number of chapters in books including the Mood disorders chapter for the Wiki project of the World Psychiatric Association (WPA). He has authored the book ‘Bipolar disorders: An Evidence-Based Guide to Manic Depression’ (Springer 2015), co-edited the WPA book ‘Advances in Psychiatry vol 3’ (Springer 2018) and the book ‘Psychobiology of behavior’ (Springer 2019) and wrote the ‘Philosophical and historical roots and the current face of Psychiatry’ is in print (Springer 2022) Dr. Fountoulakis served for 20 years as Editor of Annals of General Psychiatry (IF=2.5). Currently he serves as field editor of CNS Spectrums (IF=3.9). In the past he also served as Section Editor of Current Opinion in Psychiatry as well as guest editor in other international journals. He has received a number of national and international research awards, including the 2012 Kraepelin-Alzheimer medal of the University of Munich and the 2015 Excellence in Education Award of the WFSBP. Since 2014 he is honorary member of the WPA.

Moderator of 3 Sessions

Session Type
_COURSE
Date
Tue, 02.08.2022
Session Time
06:45 - 10:45
Room
COURSES
Session Icon
Pre-Recorded
SPECIAL SESSION
Session Type
SPECIAL SESSION
Date
Thu, 04.08.2022
Session Time
16:30 - 17:30
Room
NILE 4 - LIVE STREAMED
STATE OF THE ART SYMPOSIUM
Session Type
STATE OF THE ART SYMPOSIUM
Date
Thu, 04.08.2022
Session Time
17:50 - 18:50
Room
AMBER 2-3 - LIVE STREAMED
Session Description
Affective disorders are a major public health challenge across the world. In this symposium, we want to present recent development in the treatment of affective disorders, including treatment of anhedonia, which is a huge challenge, and the current state of the art of lithium treatment that is easily available across the world. Finally, we will present new psychotherapeutic treatments using digital tools that have the potential to considerably improve treatments in most countries.

Presenter of 4 Presentations

LITHIUM USE IN BIPOLAR DISORDERS

Date
Thu, 04.08.2022
Session Time
17:50 - 18:50
Session Type
STATE OF THE ART SYMPOSIUM
Lecture Time
17:50 - 18:10
Room
AMBER 2-3 - LIVE STREAMED

Abstract

Abstract Body

Lithium is one of the oldest and more legendary treatment options in Psychiatry, but a full systematic review of the hard evidence alone, concerning its efficacy separately for the phases and clinical facets of Bipolar disorder (BD) was lacking until recently.This speech will present such a systematic review

The PRISMA method was followed to search the MEDLINE for Randomized Controlled trials, Post-hoc analyses and Meta-analyses and review papers up to August 1st 2020, with the combination of the words ‘bipolar’, ‘manic’, ‘mania’, ‘manic depression’ and ‘manic depressive’ and ‘randomized’.

Trials and meta-analyses concerning the use of lithium either as monotherapy or in combination with other agents in adults were identified concerning acute mania (Ν=64), acute bipolar depression (Ν=78), the maintenance treatment (Ν=73) and the treatment of other issues (N=93). Treatment guidelines were also identified. Lithium is efficacious for the treatment of acute mania including concomitant psychotic symptoms. In acute bipolar depression it is efficacious only in combination with specific agents. For the maintenance phase, it is efficacious as monotherapy mainly in the prevention of manic while its efficacy for the prevention of depressive episodes is unclear. Its combinations increase its therapeutic value. It is equaly efficacious in rapid and non-rapid cycling patients, in concomitant obsessive-compulsive symptoms, alcohol and substance abuse, the neurocognitive deficit, suicidal ideation and fatigue

The current systematic review provided support for the usefulness of lithium against a broad spectrum of clinical issues in Bipolar disorder. Its efficacy is comparable to that of more recently developed agents

Hide

INTRODUCTION - COURSE 05: NEW DRUG TREATMENTS IN PSYCHIATRY

Date
Tue, 02.08.2022
Session Time
06:45 - 10:45
Session Type
_COURSE
Lecture Time
06:45 - 06:50
Room
COURSES
Session Icon
Pre-Recorded

PANELIST

Date
Thu, 04.08.2022
Session Time
09:50 - 10:50
Session Type
PSYCHIATRY WORLDWIDE
Lecture Time
09:50 - 09:50
Room
NILE 3

CONCLUSION

Date
Tue, 02.08.2022
Session Time
06:45 - 10:45
Session Type
_COURSE
Lecture Time
09:50 - 09:55
Room
COURSES
Session Icon
Pre-Recorded